Search research articles
Contact Us
Filters
Showing results (121-130 of 244) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine
T Yamauchi, B J Nowak, M J Keating, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
High-dose cytosine arabinoside in multiple myeloma
H Kantarjian, R Dreicer, B Barlogie, et al.
Journal of American College Health : J of ACH
|
September 20, 2024
Food insecurity and the consumption of plant-centered meals and high sodium foods among students at three large state universities
Janae Chatmon, Tony Kuo, Scott W Plunkett, et al.
Psychiatry
|
February 1, 1986
Perceptions of quality of life following divorce: a study of children's prognostic thinking
J W Plunkett, M Schaefer, N Kalter, et al.
Cancer Treatment Reports
|
March 1, 1979
High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells
W Plunkett, J A Benvenuto, D J Stewart, et al.
Blood
|
January 1, 1996
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions
V Gandhi, E Estey, M J Keating, et al.
Cancer Research
|
May 1, 1982
Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine
W Plunkett, R S Benjamin, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy
V Gandhi, E Estey, M Du, et al.
Lupus
|
June 5, 2004
Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus
R L Rubin, M Teodorescu, E H Beutner, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Inhibition of fludarabine metabolism by arabinosylcytosine during therapy
A Kemena, V Gandhi, D S Shewach, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 244) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine
T Yamauchi, B J Nowak, M J Keating, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
High-dose cytosine arabinoside in multiple myeloma
H Kantarjian, R Dreicer, B Barlogie, et al.
Journal of American College Health : J of ACH
|
September 20, 2024
Food insecurity and the consumption of plant-centered meals and high sodium foods among students at three large state universities
Janae Chatmon, Tony Kuo, Scott W Plunkett, et al.
Psychiatry
|
February 1, 1986
Perceptions of quality of life following divorce: a study of children's prognostic thinking
J W Plunkett, M Schaefer, N Kalter, et al.
Cancer Treatment Reports
|
March 1, 1979
High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells
W Plunkett, J A Benvenuto, D J Stewart, et al.
Blood
|
January 1, 1996
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions
V Gandhi, E Estey, M J Keating, et al.
Cancer Research
|
May 1, 1982
Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine
W Plunkett, R S Benjamin, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy
V Gandhi, E Estey, M Du, et al.
Lupus
|
June 5, 2004
Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus
R L Rubin, M Teodorescu, E H Beutner, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Inhibition of fludarabine metabolism by arabinosylcytosine during therapy
A Kemena, V Gandhi, D S Shewach, et al.
Page
of 25